Cambridge-developed SARS-CoV-2 vaccine receives £1.9million from UK government for clinical trial
26 August 2020A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9million award from the UK government.
